Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
3.940
+0.160 (4.23%)
Mar 31, 2026, 4:00 PM EDT - Market closed
Coya Therapeutics Market Cap
Coya Therapeutics has a market cap or net worth of $92.42 million as of April 1, 2026. Its market cap has decreased by -19.24% in one year.
Market Cap
92.42M
Enterprise Value
45.60M
1-Year Change
-19.24%
Ranking
Category
Stock Price
$3.94
Market Cap Chart
Since the IPO on December 29, 2022, Coya Therapeutics's market cap has increased from $11.84M to $92.42M, an increase of 680.77%. That is a compound annual growth rate of 88.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 92.42M | -23.85% |
| Dec 31, 2025 | 121.36M | 26.77% |
| Dec 31, 2024 | 95.73M | -10.29% |
| Dec 29, 2023 | 106.71M | 769.50% |
| Dec 30, 2022 | 12.27M | 3.68% |
| Dec 29, 2022 | 11.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 101.88M |
| Biomea Fusion | 95.44M |
| Seer, Inc. | 93.66M |
| Oncolytics Biotech | 90.39M |
| Spruce Biosciences | 86.49M |
| Vivani Medical | 86.34M |
| Seres Therapeutics | 86.28M |
| Fortress Biotech | 85.66M |